Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
TMO 
Thermo Fisher Scientific Inc (TMO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/31/2025: TMO (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
31 Analysts rated it
Highly popular stock, broad analyst coverage, trusted insights, strong investor interest.
1 Year Target Price $551.62
1 Year Target Price $551.62
| 18 | Strong Buy |
| 7 | Buy |
| 6 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -3.48% | Avg. Invested days 34 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/31/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 180.17B USD | Price to earnings Ratio 27.62 | 1Y Target Price 551.62 |
Price to earnings Ratio 27.62 | 1Y Target Price 551.62 | ||
Volume (30-day avg) 31 | Beta 0.77 | 52 Weeks Range 385.46 - 625.84 | Updated Date 07/31/2025 |
52 Weeks Range 385.46 - 625.84 | Updated Date 07/31/2025 | ||
Dividends yield (FY) 0.34% | Basic EPS (TTM) 17.28 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-07-22 | When Before Market | Estimate 5.23 | Actual 5.36 |
Profitability
Profit Margin 15.24% | Operating Margin (TTM) 17.92% |
Management Effectiveness
Return on Assets (TTM) 4.98% | Return on Equity (TTM) 13.42% |
Valuation
Trailing PE 27.62 | Forward PE 21.23 | Enterprise Value 209009294319 | Price to Sales(TTM) 4.17 |
Enterprise Value 209009294319 | Price to Sales(TTM) 4.17 | ||
Enterprise Value to Revenue 4.84 | Enterprise Value to EBITDA 18.56 | Shares Outstanding 377494016 | Shares Floating 377172180 |
Shares Outstanding 377494016 | Shares Floating 377172180 | ||
Percent Insiders 0.21 | Percent Institutions 92.37 |
Upturn AI SWOT
Thermo Fisher Scientific Inc
Company Overview
History and Background
Thermo Fisher Scientific Inc. was formed in 2006 through the merger of Thermo Electron and Fisher Scientific. Thermo Electron was founded in 1956, while Fisher Scientific dates back to 1902. The merger created a global leader in scientific instrumentation, reagents, and services.
Core Business Areas
- Life Sciences Solutions: Offers a broad range of reagents, instruments, and consumables used in biological and medical research, discovery, and production.
- Analytical Instruments: Provides instruments and software used for chemical analysis, materials characterization, and process control.
- Specialty Diagnostics: Develops and manufactures diagnostic test kits, reagents, and instruments for clinical laboratories and healthcare providers.
- Laboratory Products and Biopharma Services: Offers laboratory equipment, supplies, and services, including contract research and manufacturing services for the pharmaceutical and biotechnology industries.
Leadership and Structure
Marc N. Casper serves as Chairman, President, and Chief Executive Officer. The company operates with a decentralized structure, with each business segment having its own leadership team.
Top Products and Market Share
Key Offerings
- Mass Spectrometry Instruments: Analytical instruments used to measure the mass-to-charge ratio of ions. Thermo Fisher is a market leader, but faces competition from Agilent and Waters Corporation. Revenue not specifically disclosed.
- Chromatography Systems: Analytical technique used to separate and analyze complex mixtures. The company holds a significant market share, with major competitors including Agilent Technologies and Shimadzu. Revenue not specifically disclosed.
- Genetic Testing Solutions: Instruments, reagents, and assays for genomic analysis, including PCR and sequencing. Thermo Fisher is a major player, competing with Illumina and Roche. Revenue not specifically disclosed.
- Laboratory Supplies: Supplies required for research and development, for example consumables. Thermo Fisher is a major player, competing with Avantor and VWR. Revenue not specifically disclosed.
Market Dynamics
Industry Overview
The life sciences and analytical instruments industry is characterized by technological innovation, increasing demand for personalized medicine, and growing research funding globally. The IVD (in vitro diagnostics) market is also experiencing growth due to aging populations and increased disease prevalence.
Positioning
Thermo Fisher Scientific Inc. is a leading player in the industry, benefiting from its broad product portfolio, global reach, and strong brand reputation. Its scale and integrated solutions provide a competitive advantage.
Total Addressable Market (TAM)
Estimated in hundreds of billions of USD. Thermo Fisher is well-positioned, addressing multiple sub-segments with its diverse portfolio.
Upturn SWOT Analysis
Strengths
- Broad product portfolio
- Global presence
- Strong brand recognition
- Robust R&D capabilities
- Extensive service network
Weaknesses
- Integration challenges after acquisitions
- Exposure to economic cycles
- Complexity of operations
- Reliance on third-party suppliers
Opportunities
- Growing demand for personalized medicine
- Expansion in emerging markets
- Increasing research funding
- Development of new technologies
- Strategic acquisitions
Threats
- Intense competition
- Technological obsolescence
- Regulatory changes
- Economic downturns
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- Agilent Technologies (A)
- Danaher Corporation (DHR)
- Illumina (ILMN)
- Waters Corporation (WAT)
Competitive Landscape
Thermo Fisher's scale, product breadth, and service offerings provide a competitive advantage. Competitors focus on specific market segments or technologies.
Major Acquisitions
PPD
- Year: 2021
- Acquisition Price (USD millions): 17400
- Strategic Rationale: Expanded its clinical research services offering, adding capabilities and scale in the pharmaceutical and biotechnology industries.
Growth Trajectory and Initiatives
Historical Growth: Thermo Fisher has demonstrated strong historical growth through organic expansion and strategic acquisitions.
Future Projections: Analysts expect continued growth driven by innovation, market expansion, and acquisitions.
Recent Initiatives: Recent initiatives include investments in R&D, expansion of manufacturing capacity, and strategic acquisitions to strengthen its product portfolio.
Summary
Thermo Fisher is a strong company with a diverse portfolio and global reach. Its acquisition strategy and focus on innovation fuel growth. Competition and economic fluctuations pose potential challenges, requiring careful navigation. Strategic initiatives such as capacity expansion and product development are working well.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Analyst Reports
- Industry Publications
- Company Website
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Thermo Fisher Scientific Inc
Exchange NYSE | Headquaters Waltham, MA, United States | ||
IPO Launch date 1978-01-13 | Chairman, President & CEO Mr. Marc N. Casper | ||
Sector Healthcare | Industry Diagnostics & Research | Full time employees 125000 | Website https://www.thermofisher.com |
Full time employees 125000 | Website https://www.thermofisher.com | ||
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment includes clinical diagnostics offering liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics offers develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; microbiology offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; transplant diagnostics products include human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel offers consumables, diagnostic kits and reagents, equipment, instruments, solutions, and services. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.